BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1037361)

  • 41. [Endocrinologic evaluation of 61 patients with acromegaly treated with transsphenoidal removal alone, or associated with telecobalt irradiation or bromocriptine or both].
    Barceló B; Pérez C; Dávila N; Lucas T; Salto L; Alcañiz J
    Med Clin (Barc); 1983 May; 80(17):735-41. PubMed ID: 6621120
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of CB-154 in a case of acromegaly].
    Kikuchi T; Nakamura T; Suzuki H; Kasai K; Ieiri T
    Horumon To Rinsho; 1977 Dec; 25(12):1304-6. PubMed ID: 598029
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
    Molitvoslovova NN
    Sov Med; 1984; (1):24-9. PubMed ID: 6701649
    [No Abstract]   [Full Text] [Related]  

  • 44. [Twin pregnancy following bromocriptine in an acromegalic patient staying sterile after removal of a pituitary adenoma. Immunocytochemical study of the tumor (author's transl)].
    Brun JM; Bloch B; Bugnon C; Putelat R
    Ann Endocrinol (Paris); 1979; 40(6):551-2. PubMed ID: 232833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gel filtration studies of serum growth hormone in acromegaly following bromocriptine administration.
    Benker G; Sandmann K; Tharandt L; Hackenberg K; Reinwein D
    Horm Res; 1979; 11(3):151-60. PubMed ID: 488905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
    Molinatti GM; Camanni F; Massara F; Isaia GC
    Panminerva Med; 1975 Apr; 17(4):101-6. PubMed ID: 1153217
    [No Abstract]   [Full Text] [Related]  

  • 47. Failure of bromocriptine to alter the qualitative characteristics of human growth hormone in acromegaly.
    Hizuka N; Hendricks CM; Roth J; Gorden P
    Metabolism; 1984 Jun; 33(6):582-4. PubMed ID: 6727657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors determining the effectiveness of CB-154 in the treatment of acromegaly.
    Hanew K; Sasaki A; Sato S; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1983 Jan; 139(1):91-5. PubMed ID: 6404005
    [No Abstract]   [Full Text] [Related]  

  • 49. Bromocriptine treatment in acromegaly: clinical and biochemical effects.
    Halse J; Haugen HN; Bohmer T
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):464-72. PubMed ID: 335755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Letter: Bromocriptine in acromegaly.
    Teasdale G
    Lancet; 1976 Feb; 1(7957):484-5. PubMed ID: 55748
    [No Abstract]   [Full Text] [Related]  

  • 51. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L; Ljunghall S; Wide L; Boström H
    Acta Endocrinol Suppl (Copenh); 1978; 216():207-16. PubMed ID: 347863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
    Lamberts SW; Zweens M; Verschoor L; del Pozo E
    J Clin Endocrinol Metab; 1986 Jul; 63(1):16-9. PubMed ID: 2872225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [CB-154 in the treatment of acromegaly: conclusion].
    Shizume K; Demura R
    Horumon To Rinsho; 1977 Dec; 25(12):1349-53. PubMed ID: 598044
    [No Abstract]   [Full Text] [Related]  

  • 54. Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
    Chiodini PG; Liuzzi A; Muller EE; Botalla L; Cremascoli G; Oppizzi G; Verde G; Silvestrini F
    J Clin Endocrinol Metab; 1976 Aug; 43(2):356-63. PubMed ID: 950367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long-term use of parlodel in acromegaly].
    Pisarskaia IV; Zefirova GS; Ibragimova GV
    Ter Arkh; 1984; 56(10):107-10. PubMed ID: 6523351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years.
    Besser GM; Wass JA
    Med J Aust; 1978 Nov; 2(3 Suppl):31-3. PubMed ID: 745579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bromocriptine reduces growth hormone in acromegaly.
    Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B
    Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experiences with bromocriptine treatment in acromegaly--a preliminary report.
    Nilsson A
    Acta Endocrinol Suppl (Copenh); 1978; 216():217-24. PubMed ID: 274038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical results in the treatment of acromegaly with CB-154].
    Ibayashi H; Aiba H; Kato K
    Horumon To Rinsho; 1977 Dec; 25(12):1346-8. PubMed ID: 598043
    [No Abstract]   [Full Text] [Related]  

  • 60. Bromocriptine in treatment of acromegaly: Australian experience.
    Lording DW; Burger HG
    Med J Aust; 1978 Nov; 2(3 Suppl):34-5. PubMed ID: 745580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.